Adagio Medical Holdings, Inc. 8-K

What Happened
Adagio Medical Holdings, Inc. filed a Form 8-K (Item 5.08) on April 20, 2026 announcing that its 2026 Annual Meeting of Stockholders will be held on June 16, 2026. The company said the meeting time and location will be included in its definitive proxy statement to be filed with the SEC. The 8-K sets key dates and procedures for shareholder proposals, director nominations and universal-proxy notices.

Key Details

• Annual Meeting date: June 16, 2026.
• Record date to determine voting rights: close of business on April 24, 2026.
• Deadline to submit shareholder proposals for inclusion in the company’s proxy materials under SEC Rule 14a-8: April 30, 2026 (deliver to Secretary at 26051 Merit Circle, Suite 102, Laguna Hills, CA).
• Deadlines under the company’s bylaws for director nominations and for compliance with SEC Rule 14a-19 (universal proxy) are also April 30, 2026 for this meeting.

Why It Matters
These dates are the actionable deadlines for shareholders who want to submit proposals, nominate directors, or solicit proxies for the June meeting. Retail investors who plan to vote, propose items, or support alternative director nominees must meet the specified filing and delivery requirements and use the April 30 and April 24 dates to ensure their eligibility and participation.